Medicina nuclear

2022

1. 18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

   European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253

2. Amiloidosis cardíaca por transtiretina: Características clínicas y evolución de 71 pacientes

   Galicia Clínica, Vol. 83, Núm. 2, pp. 60-60

3. Enhanced quantitative method for the diagnosis of grade 1 cardiac amyloidosis in 99mTc-DPD scintigraphy

   Scientific Reports, Vol. 12, Núm. 1

4. Follicular thyroid carcinoma arising in a struma ovarii and femoral metastasis

   Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 5, pp. 325-326

5. Immunohistochemical expression of VEGFR1 in non small cell lung carcinomas: Lower VEGFR1 expression is asociated with squamous cell carcinoma subtype and high max SUV values in 18F-FDG PET

   Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 1, pp. 28-31

6. Incidental finding detected by 18F-FDG PET/CT of two cases of splenic solitary inflammatory pseudotumor

   Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, pp. S17-S19

7. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study

   European Thyroid Journal, Vol. 11, Núm. 5

8. Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy

   The oncologist, Vol. 27, Núm. 4, pp. e328-e339

9. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

   Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 2001-2017